These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 27075671

  • 1. Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.
    Kharytonchyk S, King SR, Ndongmo CB, Stilger KL, An W, Telesnitsky A.
    J Mol Biol; 2016 Jun 05; 428(11):2275-2288. PubMed ID: 27075671
    [Abstract] [Full Text] [Related]

  • 2. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL, Imamichi T, Sarafianos SG, Arnold E, Hughes SH.
    J Virol; 2004 Sep 05; 78(18):9987-97. PubMed ID: 15331732
    [Abstract] [Full Text] [Related]

  • 3. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG, MacInnes H, Bennett D, Weinstock H, Heneine W.
    J Virol; 2004 Jul 05; 78(14):7545-52. PubMed ID: 15220429
    [Abstract] [Full Text] [Related]

  • 4. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
    Miranda LR, Götte M, Liang F, Kuritzkes DR.
    Antimicrob Agents Chemother; 2005 Jul 05; 49(7):2648-56. PubMed ID: 15980332
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.
    Arion D, Kaushik N, McCormick S, Borkow G, Parniak MA.
    Biochemistry; 1998 Nov 10; 37(45):15908-17. PubMed ID: 9843396
    [Abstract] [Full Text] [Related]

  • 6. p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
    Bakhanashvili M.
    Oncogene; 2001 Nov 15; 20(52):7635-44. PubMed ID: 11753641
    [Abstract] [Full Text] [Related]

  • 7. Pre-steady-state kinetic characterization of wild type and 3'-azido-3'-deoxythymidine (AZT) resistant human immunodeficiency virus type 1 reverse transcriptase: implication of RNA directed DNA polymerization in the mechanism of AZT resistance.
    Kerr SG, Anderson KS.
    Biochemistry; 1997 Nov 18; 36(46):14064-70. PubMed ID: 9369478
    [Abstract] [Full Text] [Related]

  • 8. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
    Álvarez M, Nevot M, Mendieta J, Martínez MA, Menéndez-Arias L.
    J Biol Chem; 2018 Feb 16; 293(7):2247-2259. PubMed ID: 29275329
    [Abstract] [Full Text] [Related]

  • 9. The interaction of the reverse transcriptase of human immunodeficiency virus type 1 with 3'-terminally mispaired DNA.
    Bakhanashvili M, Hizi A.
    Arch Biochem Biophys; 1996 Oct 01; 334(1):89-96. PubMed ID: 8837743
    [Abstract] [Full Text] [Related]

  • 10. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B, Sarfati SR, Richardson CC.
    J Biol Chem; 1998 Jun 05; 273(23):14596-604. PubMed ID: 9603976
    [Abstract] [Full Text] [Related]

  • 11. Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.
    Brehm JH, Koontz D, Meteer JD, Pathak V, Sluis-Cremer N, Mellors JW.
    J Virol; 2007 Aug 05; 81(15):7852-9. PubMed ID: 17507476
    [Abstract] [Full Text] [Related]

  • 12. Single-step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3-TC.
    Krebs R, Immendörfer U, Thrall SH, Wöhrl BM, Goody RS.
    Biochemistry; 1997 Aug 19; 36(33):10292-300. PubMed ID: 9254628
    [Abstract] [Full Text] [Related]

  • 13. Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein.
    Bampi C, Bibillo A, Wendeler M, Divita G, Gorelick RJ, Le Grice SF, Darlix JL.
    J Biol Chem; 2006 Apr 28; 281(17):11736-43. PubMed ID: 16500895
    [Abstract] [Full Text] [Related]

  • 14. Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.
    Nikolenko GN, Svarovskaia ES, Delviks KA, Pathak VK.
    J Virol; 2004 Aug 28; 78(16):8761-70. PubMed ID: 15280484
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.
    Caliendo AM, Savara A, An D, DeVore K, Kaplan JC, D'Aquila RT.
    J Virol; 1996 Apr 28; 70(4):2146-53. PubMed ID: 8642636
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.
    Imamichi T, Berg SC, Imamichi H, Lopez JC, Metcalf JA, Falloon J, Lane HC.
    J Virol; 2000 Dec 28; 74(23):10958-64. PubMed ID: 11069990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.